118 related articles for article (PubMed ID: 5775739)
1. Effect of chemotherapeutic agents on chromosomes of patients with lung cancer.
Kaung DT; Swartzendruber AA
Dis Chest; 1969 Feb; 55(2):98-100. PubMed ID: 5775739
[No Abstract] [Full Text] [Related]
2. Chemotherapeutic studies in bronchogenic carcinoma by the Austrian study group.
Karrer K; Pridun N; Zwintz E
Cancer Chemother Rep 3; 1973 Mar; 4(2):207-13. PubMed ID: 4729324
[No Abstract] [Full Text] [Related]
3. High-dose cyclophosphamide versus cyclophosphamide, methotrexate, 5-FU, and hydroxyurea (CMFH) in the treatment of stage III non-small cell bronchogenic carcinoma: a randomized trial.
Pannuti F; Lelli G; Casadio M; Piana E; Di Marco AR
Cancer Treat Rep; 1980; 64(10-11):1131-4. PubMed ID: 7459899
[TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide, adriamycin, methotrexate, and procarbazine (CAMP) treatment of non-oat cell bronchogenic carcinoma.
Vogelzang NJ; Bonomi PD; Rossof AH; Wolter J
Cancer Treat Rep; 1978 Oct; 62(10):1595-7. PubMed ID: 709563
[No Abstract] [Full Text] [Related]
5. Monochemotherapy of bronchogenic carcinoma withs special reference to cell type.
Selawry OS
Cancer Chemother Rep 3; 1973 Mar; 4(2):177-88. PubMed ID: 4277763
[No Abstract] [Full Text] [Related]
6. Investigations into sister chromatid exchange in patients under cytostatic therapy.
Düker D
Hum Genet; 1981; 58(2):198-203. PubMed ID: 7287004
[No Abstract] [Full Text] [Related]
7. Hydroxyurea: effect on Cicia chromosomes previously exposed to x-rays or to radiomimetic chemicals.
Kihlman BA; Hartley B
Exp Cell Res; 1967 Dec; 48(3):629-34. PubMed ID: 4230123
[No Abstract] [Full Text] [Related]
8. [Treatment of small-cell bronchogenic carcinoma with a combination of chemotherapy and irradiation (author's transl)].
Dundalek E
Prax Klin Pneumol; 1980 Dec; 34(12):719-23. PubMed ID: 7465532
[No Abstract] [Full Text] [Related]
9. Six-drug combination chemotherapy for nonresectable bronchogenic carcinoma.
Miller CF; Weltz MD; Heim WJ; Blom J
Cancer Treat Rep; 1979 Aug; 63(8):1351-3. PubMed ID: 113094
[No Abstract] [Full Text] [Related]
10. [Cytostatic therapy of tumors of the lung].
De Marco F; Saviano G; Tenore G
Arch Monaldi; 1974; 29(3-4):326-35. PubMed ID: 4463917
[No Abstract] [Full Text] [Related]
11. Pharmacologic aspects of lung cancer chemotherapy.
Beard DB; Haskell CM
Clin Chest Med; 1986 Sep; 7(3):505-13. PubMed ID: 3533403
[TBL] [Abstract][Full Text] [Related]
12. [After care in bronchial carcinoma. Results of postoperative polychemotherapy].
Karrer K; Pridun N; Denck H
Fortschr Med; 1976 Mar; 94(7):379-85. PubMed ID: 184021
[No Abstract] [Full Text] [Related]
13. Bronchogenic carcinoma: new drugs available for study.
Slavik M; Carter SK
Cancer Chemother Rep 3; 1973 Mar; 4(2):265-9. PubMed ID: 4125744
[No Abstract] [Full Text] [Related]
14. Initial therapeutic trial of new drugs in lung cancer.
Selawry OS
Cancer Chemother Rep 3; 1973 Mar; 4(2):215-25. PubMed ID: 4729325
[No Abstract] [Full Text] [Related]
15. Lung cancer: perspectives and prospects.
Ann Intern Med; 1970 Dec; 73(6):1003-24. PubMed ID: 4336754
[No Abstract] [Full Text] [Related]
16. Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP).
Bitran JD; Desser RK; DeMeester T; Golomb HM
JAMA; 1978 Dec; 240(25):2743-6. PubMed ID: 713008
[TBL] [Abstract][Full Text] [Related]
17. Some thoughts on surgical adjuvant studies in lung cancer.
Carter SK
Cancer Chemother Rep 3; 1973 Mar; 4(2):109-17. PubMed ID: 4729314
[No Abstract] [Full Text] [Related]
18. [Prognostic factors in the chemotherapy of bronchial cancers].
Alberto P
Schweiz Med Wochenschr; 1974 Feb; 104(8):268-71. PubMed ID: 4360755
[No Abstract] [Full Text] [Related]
19. [Alteration of chromosomes in the peripheral leukocytes by administration of anti-neoplastic drugs to patients with gyneco-obstetrical tumors].
Kawasaki M
Nihon Sanka Fujinka Gakkai Zasshi; 1968 Apr; 20(4):413-22. PubMed ID: 5748487
[No Abstract] [Full Text] [Related]
20. Combination chemotherapy for non-small cell bronchogenic carcinoma with bleomycin, doxorubicin, methotrexate, and cis-dichlorodiammineplatinum(II) (BAMP).
Vogl SE; Wollner D; Kaplan BH; Berenzweig M
Cancer Treat Rep; 1980; 64(4-5):717-9. PubMed ID: 6159081
[No Abstract] [Full Text] [Related]
[Next] [New Search]
